Loading…

Grant Application Form

Complete all steps to submit your application

Pre-filled from selected grant
PAH-ADVANCE: Accelerating the Clinical Path of NTP42, a disease-modifying drug that will disrupt the future treatment of cardiopulmonary diseases, including pulmonary arterial hypertension (PAH).

European Commission · Ireland · €4.18M EUR

Back to Grant
Grant Information

Provide details about the grant you are applying for

$
Applicant Information

Tell us about yourself and your organization

$
Proposal & Supporting Documents

Provide additional details and upload your proposal document

Accepted formats: PDF, DOC, DOCX. Max size: 10MB